copium7777
Bluelighter
- Joined
- Apr 26, 2020
- Messages
- 411
Yes, spravato is "innovating" by using a less effective entaniomer that can be patented , and thus is making huge amounts of money off this.The esketamine nasal inhaler (Spravato) contains a measly 28 mg of esketamine HCl (two doses of 14mg) at a per unit MSRP of $295 USD. And you're meant to use wo or three inhalers per treatment session, let's say once every two weeks, that's 52-78 devices at a cost of $15,000-23,000 per year. That's absolutely insane. $23,000 of ketamine is Tony Montana amounts of ketamine. You could sedate a small European country for like 3 months with that. Even the worst drug dealers would think twice before trying to charge $300 for a single key bump of ket.
However, regular racemic ketamine can be had for reasonable prices if compounded by a compounding pharmacy, and prescribed by a doctor. And you don't have to jump through all. the same hoops as with spravato.
I get a measly 300 mg/month for 60$, in an intranasal spray, but you're really paying for the labor of compounding and I think many people get far bigger doses like 1.5 g/month prescribed. If I wasnt already getting refills while. Not having a pcp and while asking a doctor that I haven't seen in person for awhile to keep refilling one of my only pain meds I'd ask for the dose to be upped as mine is fairly low. But it would probably be just as cheap at a higher dose.
Not that effective for what? In what context? It has decent bioavailability and onset and works fine for pain, depression, or just mildly tripping out a little. It's true that it's not the best ROA if you want to k hole, but that's not what everyone is going forThe sad fact of reality is that intranasal ketamine is just not that terribly effective